Investigation of the effect on photosensitivity following multiple oral dosing of two different hypericum extracts in healthy men

Arzneimittel-Forschung/Drug Research

Volumn 56, Issue 3, 2006, Pages 212-221

  Schulz, Hans Ulrich ^a   Schürer, Michael ^a   Bässler, Dagmar ^b   Weiser, Dieter ^b  

^a LAFAA Laboratory for Contract Research in Clinical Pharmacology/ Biopharmaceutical Analytics GmbH   (Germany)

^b Steigerwald Arzneimittelwerk GmbH   (Germany)

Author keywords

Antidepressants; Hypericin, minimal erythema dose, photosensitivity, skin reaction; Hypericum perforatum

Indexed keywords

HYPERICIN; HYPERICUM EXTRACT; LAIF; PSEUDOHYPERICIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG FORMULATION; DRUG RESEARCH; ERYTHEMA; HUMAN; IRRADIATION; LABORATORY TEST; LIGHT INTENSITY; MALE; MULTIPLE DRUG DOSE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PHOTOSENSITIVITY; PHYSICAL EXAMINATION; SUNLIGHT; ULTRAVIOLET RADIATION; VITAL SIGN;

EID: 33645467132     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1296713     Document Type: Article

References (28)

1. Linde, K., Berner, M., Egger, M. et al., St John's wort for depression: meta-analysis of randomised controlled trials. Br. J. Psychiatry 186, 99 (2005)
2. Moore, L., B., Goodwin, B., Jones, S. A. et al., St. John's Wort induces hepatic drug metabolism through activation of the pregnan X receptor. Proc. Natl. Acad. Sci. USA 97, 7500 (2000)
3. Wentworth, J. M., Agostini, M., Love, J. et al., St. John's Wort, a herbal antidepressant, activates the steroid X receptor. J. Endocrinol. 166, R11 (2000)
4. Komoroski, B. J., Zhang, S., Cai, H. et al., Induction and inhibition of cytochromes P450 by the St. John's wort constituent hyperforin in human hepatocyte cultures. Drug Metab. Dispos. 32, 512 (2004)
5. Tian, R., Koyabu, N., Morimoto, S. et al., Functional induction and de-induction of P-glycoprotein by St. John's Wort and its ingredients in a human colon adenocarcinoma cell line. Drug Metab. Dispos. 33, 547 (2005)
6. Duran, N., Song, P-S., Hypericin and its photodynamic action. Photochem. Photobiol. 43, 677 (1986)
7. Cavarga, I., Brezani, P., Fedorocko, P. et al., Photoinduced antitumour effect of hypericin can be enhanced by fractionated dosing. Phytomedicine 12, 680 (2005)
8. Huygens, A., Kamuhabwa, A. R., van Laethem, A. et al., Enhancing the photodynamic effect of hypericin in tumour spheroids by fractionated light delivery in combination with hyperoxygenation. Int. J. Oncol. 26, 1691 (2005)
9. Giese, A. C., Hypericism. Photochem. Photobiol. Rev. 5, 229 (1980)
10. Pace, N., The etiology of hypericism, a photosensitivity produced by St. John's Wort. Am. J. Physiol. 136, 650 (1942)
11. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF), Leitlinie der Deutschen Dermatologischen Gesellschaft (DDG): Phototoxische und photoallergische Reaktionen (2003)
12. Food and Drug Administration, Guidance for Industry: Photosafety Testing. FDA, CDER, Rockville, MD, USA (2003)
13. Gulick, R. M., McAuliffe, V., Holden-Wiltse, J. et al., Phase I studies of hypericin, the active compound in St. John's Wort, as an antiretroviral agent in HIV-infected adults. AIDS clinical trials group protocols 150 and 258. Ann. Intern. Med. 130, 510 (1999)
14. Jacobson, J. M., Feinman, L., Liebes, L. et al., Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John's Wort Plant, in patients with chronic hepatitis C virus infection. Antimicrob. Agents Chemother. 45, 517 (2001)
15. Golsch, S., Vocks, E., Rakoski, J. et al., Reversible Erhöhung der Photosensitivität im UV-B-Bereich durch Johanniskrautextrakt- Präparate. Hautarzt 48, 249 (1997)
16. Cotterill, J. A., Severe phototoxic reaction to laser treatment in a patient taking St. John's Wort. J. Cosmet. Laser Ther. 3, 159 (2001)
17. Linde, K., Knüppel, L., Large-scale observational studies of hypericum extracts in patients with depressive disorders - a systematic review. Phytomedicine 12, 148 (2005)
18. Brockmöller, J., Reum, T., Bauer, S. et al., Hypericin and pseudohypericin: Pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 30 (Suppl.), 94 (1997)
19. Schempp, C. M., Müller, K., Winghofer, B. et al., Single-dose and steady-state administation of Hypericum perforatum extract (St. John's Wort) does not influence skin sensitivity to UV radiation, visible light, and solar-simulated radiation. Arch. Dermatol. 137, 512 (2001)
20. Schempp, C. M., Winghofer, B., Müller, K. et al., Effect of oral administation of Hypericum perforatum extract (St. John's Wort) on skin erythema and pigmentation induced by UVB, UVA, visible light and solar simulated radiation. Phytother. Res. 17, 141 (2003)
21. DIN 5031-10, Strahlungsphysik und Lichttechnik, Teil 10: Photobiologisch wirksame Strahlung. Deutsches Institut für Normung, Berlin (2000)
22. Schulz, H.-U., Schürer, M., Bässler, D. et al., Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet. Arzneim.-Forsch./Drug Res. 55, 15 (2005)
23. Schulz, H.-U., Schürer, M., Bässler, D. et al., Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dosing with a hypericum extract containing tablet in healthy male volunteers. Arzneim.-Forsch./Drug Res. 55, 561 (2005)
24. Boccumini, L. E., Fowler, C. L., Campbell, T. A. et al., Photoreaction potential of orally administered levofloxaein in healthy subjects. Ann. Pharmacother. 34, 453 (2000)
25. Gould, J. W., Mercurio, M. G., Elmets, C. A., Cutaneous photosensitivity diseases induced by exogenous agents. J. Am. Acad. Dermatol. 33, 551 (1995)
26. Schempp, C. M., Simon-Haarhaus, B., Heine, A. et al., In vitro and in vivo activation of hypericin with the incoherent light source PDT 1200 SOA (520-750 nm) and with solar simulated radiation (290-2500 nm). Photodermatol. Photoimmunol. Photomed. 15, 13 (1999)
27. Schempp, C. M., Müller, K. A., Winghofer, B. et al., Johanniskraut (Hypericum perforatum L.). Eine Pflanze mit Relevanz für die Dermatologie. Hautarzt 53, 316 (2002)
28. Schempp, C. M., Winghofer, B., Langheinrich, M. et al., Hypericin levels in human serum and interstitial skin blister fluid after oral singe-dose and steady-state administration of Hypericum perforatum extract (St. John's Wort). Skin Pharmacol. Appl. Skin Physiol. 12, 299 (1999)